Haemonetics Corporation
HAE
$53.45
-$0.29-0.54%
NYSE
| 06/28/2025 | 03/29/2025 | 12/28/2024 | 09/28/2024 | 06/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 321.39M | 330.60M | 348.54M | 345.51M | 336.17M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 321.39M | 330.60M | 348.54M | 345.51M | 336.17M |
| Cost of Revenue | 129.54M | 131.44M | 148.63M | 154.31M | 156.88M |
| Gross Profit | 191.86M | 199.16M | 199.92M | 191.20M | 179.29M |
| SG&A Expenses | 99.95M | 116.69M | 105.74M | 104.72M | 101.38M |
| Depreciation & Amortization | 11.39M | 11.30M | 12.23M | 12.26M | 12.47M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 256.46M | 273.74M | 282.43M | 287.82M | 285.19M |
| Operating Income | 64.94M | 56.86M | 66.11M | 57.69M | 50.98M |
| Income Before Tax | 45.17M | 70.74M | 49.92M | 44.70M | 46.71M |
| Income Tax Expenses | 11.14M | 12.76M | 12.42M | 10.87M | 8.34M |
| Earnings from Continuing Operations | 34.03M | 57.98M | 37.49M | 33.83M | 38.37M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.03M | 57.98M | 37.49M | 33.83M | 38.37M |
| EBIT | 64.94M | 56.86M | 66.11M | 57.69M | 50.98M |
| EBITDA | 93.70M | 78.37M | 95.14M | 86.91M | 80.11M |
| EPS Basic | 0.71 | 1.18 | 0.75 | 0.66 | 0.75 |
| Normalized Basic EPS | 0.73 | 0.55 | 0.71 | 0.62 | 0.71 |
| EPS Diluted | 0.70 | 1.18 | 0.74 | 0.66 | 0.74 |
| Normalized Diluted EPS | 0.73 | 0.55 | 0.70 | 0.62 | 0.70 |
| Average Basic Shares Outstanding | 48.11M | 49.19M | 50.29M | 50.90M | 50.94M |
| Average Diluted Shares Outstanding | 48.35M | 49.48M | 50.64M | 51.24M | 51.56M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |